Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver Nitrate Pleurodesis for Malignant Pleural Effusion
NCT01125124Phase 2Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Aug 2009
- Primary completion
- Dec 2010
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of silver nitrate in malignant pleural effusion (MPE), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Chest pain on the first five days after pleurodesis at 5 days. Status: unknown.
02
Drugs
silver nitrate
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT01125124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01125124.